QVIDTVM Management LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 6, 2025), QVIDTVM Management LLC reported 8 stock positions worth $92.9 million. Its top holding was Solventum (SOLV) at 39.0% of the portfolio, followed by Bio-Rad Laboratories-A (BIO, 38.2%) and Coty Class A (COTY, 7.0%). Compared with Q2 2025, it added to 5 and reduced 3. The biggest buy was Bio-Rad Laboratories-A (BIO, shares +0%) and the biggest sale Ermenegildo Zegna (ZGN, shares −100%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $92.9M (Q3 2025)
- SEC Filing
- 0001912226-25-000005 ↗ filed Nov 6, 2025
Holdings Value
Holdings 8 stocks · $92.9M
| SOLV Solventum Corp. | 39.02% | 496,687 | $36.3M | Reduce -3.3% |
| BIO Bio-Rad Laboratories-A | 38.17% | 126,480 | $35.5M | Add +0.3% |
| COTY Coty Inc. Class A | 7.00% | 1,610,853 | $6.5M | Add +0.4% |
| XRAY Dentsply Sirona Inc. | 6.76% | 495,166 | $6.3M | Add +6.8% |
| BRC INC-A | 5.61% | 3,340,681 | $5.2M | Add +1.2% |
| WAB Wabtec Corp. | 2.07% | 9,604 | $1.9M | Reduce -13.5% |
| ZGN Ermenegildo Zegna NV | 1.18% | 1,400 | $1.1M | Reduce -99.7% |
| RTO Rentokil Initial PLC-SP ADR | 0.18% | 1,704,486 | $169K | Add +669.1% |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |